Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph
GERMANTOWN, Md., Aug. 30, 2022 (GLOBE NEWSWIRE) — The regenerative medicine company Seraxis Inc. today announced the appointment of Paul Strumph, M.D. as Chief Medical Officer. Dr. Strumph is an endocrinology and diabetes care and research specialist with a successful career of bringing anti-diabetes treatments to market. He will drive the company’s clinical and medical […]
Can stem cells shape the future of medicine? | Esther Wolfs
At this very moment, research is being done on Charcot-Marie-Tooth disease type 1A. Esther is a leading researcher in this field and will tell you more about how cancer and other global diseases can be cured using this new technique. Esther uses stem cells in anticancer therapy and as a model to study Charcot-Marie-Tooth disease […]
Insulin-Stimulated Mesenchymal Stem Cells in Wound Healing
UCI Sue and Bill Gross Stem Cell Research Center Virtual Community Lecture featuring Ronke Olabisi, PhD discussing mesenchymal stem cells in wound healing.
Biorep Technologies, Inc. Joins the Tetra Partner Network to Accelerate Research into Stem-Cell Derived Insulin to Cure Diabetes
BOSTON, May 31, 2022 /PRNewswire/ — TetraScience, the R&D Data Cloud company, announced today that Biorep Technologies, Inc., the leading provider of scientific instruments that help pharmaceutical companies and leading universities research cures for Type 1 and Type 2 diabetes, has joined the Tetra Partner Network. The partnership builds on a joint deployment of Biorep’s […]
Is Reversing Type-1 Diabetes In The Horizon?
Did you know that Type-1 diabetes is a life-threatening autoimmune disease? If not, you’re not alone. Many people are unaware of the seriousness of this disease. Cause of Type-1 Diabetes Type-1 diabetes is caused by the body’s immune system attacking and destroying the insulin-producing cells in the pancreas. This means that the body can no […]